Article: Metastatic disease is relatively common in cases of breast cancer.(Metastatic breast cancer)(Report)

Approximately 40% of all patients with breast cancer will relapse, which represents a failure of adjuvant therapy to control micrometastatic disease. Even though most patients will have a relapse within the first 5 years after treatment, they can relapse indefinitely; therefore breast cancer patients should be followed up for life.

Metastatic disease is incurable, but because of improved therapy survival of patients has been prolonged. The overall median time of survival is 2 years from initial diagnosis of metastases, but in some circumstances patients may live much longer.

The following factors affect long-term survival of patients with metastatic ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!